期刊文献+

低分子肝素相对分子质量测定方法 被引量:2

An introduction of methods for determination of relative molecular mass of low molecular weight heparin
原文传递
导出
摘要 相对分子质量是低分子肝素的重要质量控制指标,本文对5种常用的LMWH相对分子质量测定方法(高效分子排阻色谱法、聚丙烯酰胺凝胶电泳法、光散射法、质谱法、核磁共振法)进行综述。5种方法特点各异,可以根据实验室条件和对相对分子质量测量的要求选择。 To review five methods for determination of relative molecular mass of low molecular weight heparin,such as high performance size exclusive chromatography,polyacrylamide gradient gel electrophoresis,multiangle laser light scattering,nuclear magnetic resonance and mass spectrometry.Five methods have their own characteristic.It can be chosen by the laboratory conditions or by the measurement demands of the relative molecular weight.
出处 《药物分析杂志》 CAS CSCD 北大核心 2011年第2期402-407,共6页 Chinese Journal of Pharmaceutical Analysis
基金 十一五"重大新药创制"项目(2008ZX09504)
关键词 低分子肝素 相对分子质量测定 高效分子排阻色谱 聚丙烯酰胺凝胶电泳 多角度激光光散射 质谱 核磁共振 low molecular weight heparin relative molecular mass high performance size exclusive chromatography polyacrylamide gradient gel electrophoresis multi-angle laser light scattering mass spectrometry nuclear magnetic resonance
  • 相关文献

参考文献31

  • 1姬胜利,张天民.肝素与低分子肝素的研究进展[J].中国生化药物杂志,1996,17(5):216-219. 被引量:33
  • 2HUANG Shou-wu(黄寿吾),WANG Hong-li(王鸿利).Heparin Clinical Application(肝素临床应用).Zhengzhou(郑州):Henan Medical University Press(河南医科大学出版社),1999.251.
  • 3曹苹,张麟生.低分子肝素的抗凝与抗血栓作用[J].中国医院药学杂志,2001,21(5):289-291. 被引量:38
  • 4BP.2009.VolⅠ&Ⅱ:Monograghs:Medicine and Pharmaceutical Substances,Low-molecular-weight heparins.
  • 5EP.6.0.2041.
  • 6USP32-NF27:2253.
  • 7吕志华,赵峡,于广利,王远红,徐家敏.硫酸多糖电泳方法的研究[J].中国生化药物杂志,2002,23(1):17-18. 被引量:7
  • 8HE Zhong-xiao(何忠效),ZHANG Shu-zheng(张树政).Electrophoresis (电泳).Beijing(北京):Science Press(科学出版社),1999.11.
  • 9ZHANG Wei-jie(张惟杰),Biochemical Techniques Research of Carbohydrate Complex (糖复合物生化研究技术).Zhejiang(浙江):Zhejiang University Press(浙江大学出版社),1998.75.
  • 10Edens RE,Al-Hakim,Weiler JM,et al.Gradient polyacrlamide gel electrophoresis for determination of molecular weight of heparin preparations and low-molecular-weight heparin derivatives.J Parm Sci,1992,81(8):823.

二级参考文献39

  • 1王勇,刘志强,宋凤瑞,刘淑莹.附子配伍原则的电喷雾质谱研究[J].药学学报,2003,38(6):451-454. 被引量:28
  • 2卫生部医政司.全国临床检验操作规程(第1版)[M].南京:东南大学出版社,1992.24.
  • 3EP 5.0[S]. 2004: 1717-1719.
  • 4JAMES E, PATRICL N S. Absolute molecular weight distribution of low-molecular-weight heparins by size-exclusion chromatograghy with multiangle laser light scattering detection[J]. Anal Biochem, 1997, 245 (2): 231-241.
  • 5WYATT P J. Light scattering and absolute characterization of macromolecules[J].Anal Chim Acta, 1993, 272(1): 1-40.
  • 6张天明,中国生化药物杂志,1998年,19卷,4期,194页
  • 7卫生部医政司,全国临床检验操作规程,1992年,24页
  • 8Hoffman R,Paper FH.Selective inhibition of cell poliferation and DNA synthesis by the polysulphated carbohydrate-carrageenan[J].Cann Chemother Pharmacol,1995,36:325-334.
  • 9Nada H,Amano H,Arashima K,et al.Antitumor activity of marine algae[J].Hydrobiologia,1990,204:577-584.
  • 10Damonte E,Neyts J,Pujol CA,et al.Antivirus activity of a ulfatedpolysaccharide from the red seaweed Nothogenia fastigiata[J].Biochemical pharmacology,1994,47(12):2187-2192.

共引文献113

同被引文献16

  • 1Van Dedem G. Collaborative assay of heparin molecular weights by high performance size exclusion chromatography. Report, Diosynth BV, Oss, The Netherlands, 1985.
  • 2Sugisaka N,Petrasek FJ. Rapid molecular size characterization of hep- arins by high pressure liquid chromatography. Fed Proc, 1977,36 : 89.
  • 3Harenberg J, Jan X, Vries DE. Characterization of heparins by high performance size exclusion liquid chromatography. J Chromatogr A, 1983.261,287.
  • 4Muller D, Ndoume, Jozefonvicz. High - pressure size - exclusion chro- matography of anticoagulant materials. J Chromatogr A, 1984,297:351.
  • 5Jeske W, Ahsan A, Fareed J. Molecular weight profiling of low molec- ular weight heparins utilizing a heparinase degraded oligosaccharide mixture as a calibrator. Thromb Res, 1993,70 (1) :39.
  • 6Mulloy B, Gee C, Wheeler SF, et al. Molecular weight measurements of low molecular weight heparins by gel permeation chromatography. J Thromb Haemost,1997,77 (4) :668.
  • 7Mulloy B, Heath A, Emmanulle M, et al. A collaborative study to es- tablish the 2nd intermational standard low molecular weight heparin for molecular weight calibration. Expert Committee on Biological Standardization, Geneva, 2007.
  • 8Ye FC, Kuang Y, Chen S, et al. Characteristics of low molecular weight heparin production by an ultrafiltration membrane bioreactor u- sing maltose binding protein fused heparinase I. Biochem Eng J, 2009,46 : 193.
  • 9WHO Intemational Standard 2"a International Standard Low Molecu- lar Weight Heparin for Molecular Weight Calibration, NIBSC code 05/112 ,Instructions for Use. National Institute for Biological Stand- ards (NIBSC) ,2008, Version 3.0.
  • 10Roger D. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events: US, 5389618[P]. 1995-02-14.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部